 | • レポートコード：GIR-107A14316 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、クレブシエラニューモニエ感染症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。クレブシエラニューモニエ感染症治療薬の種類別市場規模（ATI-1503、CA-824、CC-1807、セフィデロコル、デディオ-1454、EBX-004、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・クレブシエラニューモニエ感染症治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Acies Bio doo、Appili Therapeutics、Debiopharm International SA、Evaxion Biotech ApS、F. Hoffmann-La Roche Ltd、FOB Synthesis Inc、ImmunoClin Corp、Innovation Pharmaceuticals Inc、Kyorin Pharmaceutical Co Ltd、Melinta Therapeutics Inc、Nosopharm SAS、Peptilogics Inc、Pfizer Inc、Phico Therapeutics Ltd、Sarepta Therapeutics Inc、Shionogi & Co Ltd、Syntiron LLC、Tetraphase Pharmaceuticals Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ATI-1503、CA-824、CC-1807、セフィデロコル、デディオ-1454、EBX-004、その他 ・用途別分析2016年-2026年：病院、クリニック、その他 ・クレブシエラニューモニエ感染症治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・クレブシエラニューモニエ感染症治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・クレブシエラニューモニエ感染症治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・クレブシエラニューモニエ感染症治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・クレブシエラニューモニエ感染症治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Klebsiella Pneumoniae Infection Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Klebsiella Pneumoniae Infection Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Klebsiella Pneumoniae Infection Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Klebsiella Pneumoniae Infection Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
ATI-1503
CA-824
CC-1807
Cefiderocol
Debio-1454
EBX-004
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Klebsiella Pneumoniae Infection Drug market are listed below:
Acies Bio doo
Appili Therapeutics
Debiopharm International SA
Evaxion Biotech ApS
F. Hoffmann-La Roche Ltd
FOB Synthesis Inc
ImmunoClin Corp
Innovation Pharmaceuticals Inc
Kyorin Pharmaceutical Co Ltd
Melinta Therapeutics Inc
Nosopharm SAS
Peptilogics Inc
Pfizer Inc
Phico Therapeutics Ltd
Sarepta Therapeutics Inc
Shionogi & Co Ltd
Syntiron LLC
Tetraphase Pharmaceuticals Inc
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Klebsiella Pneumoniae Infection Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Klebsiella Pneumoniae Infection Drug, with price, sales, revenue and global market share of Klebsiella Pneumoniae Infection Drug from 2019 to 2021.
Chapter 3, the Klebsiella Pneumoniae Infection Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Klebsiella Pneumoniae Infection Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Klebsiella Pneumoniae Infection Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Klebsiella Pneumoniae Infection Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Klebsiella Pneumoniae Infection Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Klebsiella Pneumoniae Infection Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 ATI-1503
1.2.3 CA-824
1.2.4 CC-1807
1.2.5 Cefiderocol
1.2.6 Debio-1454
1.2.7 EBX-004
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Klebsiella Pneumoniae Infection Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Klebsiella Pneumoniae Infection Drug Market Size & Forecast
1.4.1 Global Klebsiella Pneumoniae Infection Drug Sales in Value (2016-2026))
1.4.2 Global Klebsiella Pneumoniae Infection Drug Sales in Volume (2016-2026)
1.4.3 Global Klebsiella Pneumoniae Infection Drug Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Klebsiella Pneumoniae Infection Drug Production Capacity Analysis
1.5.1 Global Klebsiella Pneumoniae Infection Drug Total Production Capacity (2016-2026)
1.5.2 Global Klebsiella Pneumoniae Infection Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Klebsiella Pneumoniae Infection Drug Market Drivers
1.6.2 Klebsiella Pneumoniae Infection Drug Market Restraints
1.6.3 Klebsiella Pneumoniae Infection Drug Trends Analysis
2 Manufacturers Profiles
2.1 Acies Bio doo
2.1.1 Acies Bio doo Details
2.1.2 Acies Bio doo Major Business
2.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Product and Services
2.1.4 Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Appili Therapeutics
2.2.1 Appili Therapeutics Details
2.2.2 Appili Therapeutics Major Business
2.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Product and Services
2.2.4 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Debiopharm International SA
2.3.1 Debiopharm International SA Details
2.3.2 Debiopharm International SA Major Business
2.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Product and Services
2.3.4 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Evaxion Biotech ApS
2.4.1 Evaxion Biotech ApS Details
2.4.2 Evaxion Biotech ApS Major Business
2.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Product and Services
2.4.4 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 F. Hoffmann-La Roche Ltd
2.5.1 F. Hoffmann-La Roche Ltd Details
2.5.2 F. Hoffmann-La Roche Ltd Major Business
2.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Product and Services
2.5.4 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 FOB Synthesis Inc
2.6.1 FOB Synthesis Inc Details
2.6.2 FOB Synthesis Inc Major Business
2.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Product and Services
2.6.4 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 ImmunoClin Corp
2.7.1 ImmunoClin Corp Details
2.7.2 ImmunoClin Corp Major Business
2.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Product and Services
2.7.4 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Innovation Pharmaceuticals Inc
2.8.1 Innovation Pharmaceuticals Inc Details
2.8.2 Innovation Pharmaceuticals Inc Major Business
2.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product and Services
2.8.4 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Kyorin Pharmaceutical Co Ltd
2.9.1 Kyorin Pharmaceutical Co Ltd Details
2.9.2 Kyorin Pharmaceutical Co Ltd Major Business
2.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Product and Services
2.9.4 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Melinta Therapeutics Inc
2.10.1 Melinta Therapeutics Inc Details
2.10.2 Melinta Therapeutics Inc Major Business
2.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product and Services
2.10.4 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Nosopharm SAS
2.11.1 Nosopharm SAS Details
2.11.2 Nosopharm SAS Major Business
2.11.3 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Product and Services
2.11.4 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Peptilogics Inc
2.12.1 Peptilogics Inc Details
2.12.2 Peptilogics Inc Major Business
2.12.3 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Product and Services
2.12.4 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Pfizer Inc
2.13.1 Pfizer Inc Details
2.13.2 Pfizer Inc Major Business
2.13.3 Pfizer Inc Klebsiella Pneumoniae Infection Drug Product and Services
2.13.4 Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Phico Therapeutics Ltd
2.14.1 Phico Therapeutics Ltd Details
2.14.2 Phico Therapeutics Ltd Major Business
2.14.3 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Product and Services
2.14.4 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Sarepta Therapeutics Inc
2.15.1 Sarepta Therapeutics Inc Details
2.15.2 Sarepta Therapeutics Inc Major Business
2.15.3 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product and Services
2.15.4 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Shionogi & Co Ltd
2.16.1 Shionogi & Co Ltd Details
2.16.2 Shionogi & Co Ltd Major Business
2.16.3 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Product and Services
2.16.4 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Syntiron LLC
2.17.1 Syntiron LLC Details
2.17.2 Syntiron LLC Major Business
2.17.3 Syntiron LLC Klebsiella Pneumoniae Infection Drug Product and Services
2.17.4 Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Tetraphase Pharmaceuticals Inc
2.18.1 Tetraphase Pharmaceuticals Inc Details
2.18.2 Tetraphase Pharmaceuticals Inc Major Business
2.18.3 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product and Services
2.18.4 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Klebsiella Pneumoniae Infection Drug Sales by Manufacturer
3.1 Global Klebsiella Pneumoniae Infection Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Klebsiella Pneumoniae Infection Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Klebsiella Pneumoniae Infection Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Klebsiella Pneumoniae Infection Drug Manufacturer Market Share
3.4.2 Top 6 Klebsiella Pneumoniae Infection Drug Manufacturer Market Share
3.5 Global Klebsiella Pneumoniae Infection Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Klebsiella Pneumoniae Infection Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Klebsiella Pneumoniae Infection Drug Market Size by Region
4.1.1 Global Klebsiella Pneumoniae Infection Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Klebsiella Pneumoniae Infection Drug Revenue by Region (2016-2026)
4.2 North America Klebsiella Pneumoniae Infection Drug Revenue (2016-2026)
4.3 Europe Klebsiella Pneumoniae Infection Drug Revenue (2016-2026)
4.4 Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue (2016-2026)
4.5 South America Klebsiella Pneumoniae Infection Drug Revenue (2016-2026)
4.6 Middle East and Africa Klebsiella Pneumoniae Infection Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Klebsiella Pneumoniae Infection Drug Sales in Volume by Type (2016-2026)
5.2 Global Klebsiella Pneumoniae Infection Drug Revenue by Type (2016-2026)
5.3 Global Klebsiella Pneumoniae Infection Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Klebsiella Pneumoniae Infection Drug Sales in Volume by Application (2016-2026)
6.2 Global Klebsiella Pneumoniae Infection Drug Revenue by Application (2016-2026)
6.3 Global Klebsiella Pneumoniae Infection Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2026)
7.2 North America Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2026)
7.3 North America Klebsiella Pneumoniae Infection Drug Market Size by Country
7.3.1 North America Klebsiella Pneumoniae Infection Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Klebsiella Pneumoniae Infection Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2026)
8.2 Europe Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2026)
8.3 Europe Klebsiella Pneumoniae Infection Drug Market Size by Country
8.3.1 Europe Klebsiella Pneumoniae Infection Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Klebsiella Pneumoniae Infection Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Klebsiella Pneumoniae Infection Drug Market Size by Region
9.3.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2026)
10.2 South America Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2026)
10.3 South America Klebsiella Pneumoniae Infection Drug Market Size by Country
10.3.1 South America Klebsiella Pneumoniae Infection Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Klebsiella Pneumoniae Infection Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Klebsiella Pneumoniae Infection Drug Market Size by Country
11.3.1 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Klebsiella Pneumoniae Infection Drug Typical Distributors
12.3 Klebsiella Pneumoniae Infection Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Klebsiella Pneumoniae Infection Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Klebsiella Pneumoniae Infection Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Acies Bio doo Basic Information, Manufacturing Base and Competitors
Table 4. Acies Bio doo Major Business
Table 5. Acies Bio doo Klebsiella Pneumoniae Infection Drug Product and Services
Table 6. Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Appili Therapeutics Basic Information, Manufacturing Base and Competitors
Table 8. Appili Therapeutics Major Business
Table 9. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Product and Services
Table 10. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Debiopharm International SA Basic Information, Manufacturing Base and Competitors
Table 12. Debiopharm International SA Major Business
Table 13. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Product and Services
Table 14. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Evaxion Biotech ApS Basic Information, Manufacturing Base and Competitors
Table 16. Evaxion Biotech ApS Major Business
Table 17. Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Product and Services
Table 18. Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 20. F. Hoffmann-La Roche Ltd Major Business
Table 21. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Product and Services
Table 22. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. FOB Synthesis Inc Basic Information, Manufacturing Base and Competitors
Table 24. FOB Synthesis Inc Major Business
Table 25. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Product and Services
Table 26. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. ImmunoClin Corp Basic Information, Manufacturing Base and Competitors
Table 28. ImmunoClin Corp Major Business
Table 29. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Product and Services
Table 30. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Innovation Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 32. Innovation Pharmaceuticals Inc Major Business
Table 33. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product and Services
Table 34. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Kyorin Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 36. Kyorin Pharmaceutical Co Ltd Major Business
Table 37. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Product and Services
Table 38. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Melinta Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 40. Melinta Therapeutics Inc Major Business
Table 41. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product and Services
Table 42. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Nosopharm SAS Basic Information, Manufacturing Base and Competitors
Table 44. Nosopharm SAS Major Business
Table 45. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Product and Services
Table 46. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Peptilogics Inc Basic Information, Manufacturing Base and Competitors
Table 48. Peptilogics Inc Major Business
Table 49. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Product and Services
Table 50. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 52. Pfizer Inc Major Business
Table 53. Pfizer Inc Klebsiella Pneumoniae Infection Drug Product and Services
Table 54. Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Phico Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 56. Phico Therapeutics Ltd Major Business
Table 57. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Product and Services
Table 58. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Sarepta Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 60. Sarepta Therapeutics Inc Major Business
Table 61. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product and Services
Table 62. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Shionogi & Co Ltd Basic Information, Manufacturing Base and Competitors
Table 64. Shionogi & Co Ltd Major Business
Table 65. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Product and Services
Table 66. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Syntiron LLC Basic Information, Manufacturing Base and Competitors
Table 68. Syntiron LLC Major Business
Table 69. Syntiron LLC Klebsiella Pneumoniae Infection Drug Product and Services
Table 70. Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Tetraphase Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 72. Tetraphase Pharmaceuticals Inc Major Business
Table 73. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product and Services
Table 74. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Global Klebsiella Pneumoniae Infection Drug Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 76. Global Klebsiella Pneumoniae Infection Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 77. Market Position of Manufacturers in Klebsiella Pneumoniae Infection Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 78. Global Klebsiella Pneumoniae Infection Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 79. Head Office and Klebsiella Pneumoniae Infection Drug Production Site of Key Manufacturer
Table 80. Klebsiella Pneumoniae Infection Drug New Entrant and Capacity Expansion Plans
Table 81. Klebsiella Pneumoniae Infection Drug Mergers & Acquisitions in the Past Five Years
Table 82. Global Klebsiella Pneumoniae Infection Drug Sales by Region (2016-2021e) & (K Pcs)
Table 83. Global Klebsiella Pneumoniae Infection Drug Sales by Region (2021-2026) & (K Pcs)
Table 84. Global Klebsiella Pneumoniae Infection Drug Revenue by Region (2016-2021e) & (USD Million)
Table 85. Global Klebsiella Pneumoniae Infection Drug Revenue by Region (2021-2026) & (USD Million)
Table 86. Global Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2021e) & (K Pcs)
Table 87. Global Klebsiella Pneumoniae Infection Drug Sales by Type (2021-2026) & (K Pcs)
Table 88. Global Klebsiella Pneumoniae Infection Drug Revenue by Type (2016-2021e) & (USD Million)
Table 89. Global Klebsiella Pneumoniae Infection Drug Revenue by Type (2021-2026) & (USD Million)
Table 90. Global Klebsiella Pneumoniae Infection Drug Price by Type (2016-2021e) & (USD/Pcs)
Table 91. Global Klebsiella Pneumoniae Infection Drug Price by Type (2021-2026) & (USD/Pcs)
Table 92. Global Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2021e) & (K Pcs)
Table 93. Global Klebsiella Pneumoniae Infection Drug Sales by Application (2021-2026) & (K Pcs)
Table 94. Global Klebsiella Pneumoniae Infection Drug Revenue by Application (2016-2021e) & (USD Million)
Table 95. Global Klebsiella Pneumoniae Infection Drug Revenue by Application (2021-2026) & (USD Million)
Table 96. Global Klebsiella Pneumoniae Infection Drug Price by Application (2016-2021e) & (USD/Pcs)
Table 97. Global Klebsiella Pneumoniae Infection Drug Price by Application (2021-2026) & (USD/Pcs)
Table 98. North America Klebsiella Pneumoniae Infection Drug Sales by Country (2016-2021e) & (K Pcs)
Table 99. North America Klebsiella Pneumoniae Infection Drug Sales by Country (2021-2026) & (K Pcs)
Table 100. North America Klebsiella Pneumoniae Infection Drug Revenue by Country (2016-2021e) & (USD Million)
Table 101. North America Klebsiella Pneumoniae Infection Drug Revenue by Country (2021-2026) & (USD Million)
Table 102. North America Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2021e) & (K Pcs)
Table 103. North America Klebsiella Pneumoniae Infection Drug Sales by Type (2021-2026) & (K Pcs)
Table 104. North America Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2021e) & (K Pcs)
Table 105. North America Klebsiella Pneumoniae Infection Drug Sales by Application (2021-2026) & (K Pcs)
Table 106. Europe Klebsiella Pneumoniae Infection Drug Sales by Country (2016-2021e) & (K Pcs)
Table 107. Europe Klebsiella Pneumoniae Infection Drug Sales by Country (2021-2026) & (K Pcs)
Table 108. Europe Klebsiella Pneumoniae Infection Drug Revenue by Country (2016-2021e) & (USD Million)
Table 109. Europe Klebsiella Pneumoniae Infection Drug Revenue by Country (2021-2026) & (USD Million)
Table 110. Europe Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2021e) & (K Pcs)
Table 111. Europe Klebsiella Pneumoniae Infection Drug Sales by Type (2021-2026) & (K Pcs)
Table 112. Europe Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2021e) & (K Pcs)
Table 113. Europe Klebsiella Pneumoniae Infection Drug Sales by Application (2021-2026) & (K Pcs)
Table 114. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales by Region (2016-2021e) & (K Pcs)
Table 115. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales by Region (2021-2026) & (K Pcs)
Table 116. Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue by Region (2016-2021e) & (USD Million)
Table 117. Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue by Region (2021-2026) & (USD Million)
Table 118. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2021e) & (K Pcs)
Table 119. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales by Type (2021-2026) & (K Pcs)
Table 120. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2021e) & (K Pcs)
Table 121. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales by Application (2021-2026) & (K Pcs)
Table 122. South America Klebsiella Pneumoniae Infection Drug Sales by Country (2016-2021e) & (K Pcs)
Table 123. South America Klebsiella Pneumoniae Infection Drug Sales by Country (2021-2026) & (K Pcs)
Table 124. South America Klebsiella Pneumoniae Infection Drug Revenue by Country (2016-2021e) & (USD Million)
Table 125. South America Klebsiella Pneumoniae Infection Drug Revenue by Country (2021-2026) & (USD Million)
Table 126. South America Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2021e) & (K Pcs)
Table 127. South America Klebsiella Pneumoniae Infection Drug Sales by Type (2021-2026) & (K Pcs)
Table 128. South America Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2021e) & (K Pcs)
Table 129. South America Klebsiella Pneumoniae Infection Drug Sales by Application (2021-2026) & (K Pcs)
Table 130. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Country (2016-2021e) & (K Pcs)
Table 131. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Country (2021-2026) & (K Pcs)
Table 132. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue by Country (2016-2021e) & (USD Million)
Table 133. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue by Country (2021-2026) & (USD Million)
Table 134. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2021e) & (K Pcs)
Table 135. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Type (2021-2026) & (K Pcs)
Table 136. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2021e) & (K Pcs)
Table 137. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Application (2021-2026) & (K Pcs)
Table 138. Direct Channel Pros & Cons
Table 139. Indirect Channel Pros & Cons
Table 140. Klebsiella Pneumoniae Infection Drug Typical Distributors
Table 141. Klebsiella Pneumoniae Infection Drug Typical Customers
List of Figures
Figure 1. Klebsiella Pneumoniae Infection Drug Picture
Figure 2. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Type in 2020
Figure 3. ATI-1503
Figure 4. CA-824
Figure 5. CC-1807
Figure 6. Cefiderocol
Figure 7. Debio-1454
Figure 8. EBX-004
Figure 9. Others
Figure 10. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Application in 2020
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Others
Figure 14. Global Klebsiella Pneumoniae Infection Drug Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 15. Global Klebsiella Pneumoniae Infection Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Klebsiella Pneumoniae Infection Drug Sales (2016-2026) & (K Pcs)
Figure 17. Global Klebsiella Pneumoniae Infection Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 18. Global Klebsiella Pneumoniae Infection Drug Production Capacity (2016-2026) & (K Pcs)
Figure 19. Global Klebsiella Pneumoniae Infection Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Klebsiella Pneumoniae Infection Drug Market Drivers
Figure 21. Klebsiella Pneumoniae Infection Drug Market Restraints
Figure 22. Klebsiella Pneumoniae Infection Drug Market Trends
Figure 23. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Manufacturer in 2020
Figure 24. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Manufacturer in 2020
Figure 25. Klebsiella Pneumoniae Infection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Klebsiella Pneumoniae Infection Drug Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Klebsiella Pneumoniae Infection Drug Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Region (2016-2026)
Figure 29. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Region (2016-2026)
Figure 30. North America Klebsiella Pneumoniae Infection Drug Revenue (2016-2026) & (USD Million)
Figure 31. Europe Klebsiella Pneumoniae Infection Drug Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue (2016-2026) & (USD Million)
Figure 33. South America Klebsiella Pneumoniae Infection Drug Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue (2016-2026) & (USD Million)
Figure 35. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2016-2026)
Figure 36. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Type (2016-2026)
Figure 37. Global Klebsiella Pneumoniae Infection Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 38. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2016-2026)
Figure 39. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Application (2016-2026)
Figure 40. Global Klebsiella Pneumoniae Infection Drug Price by Application (2016-2026) & (USD/Pcs)
Figure 41. North America Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2016-2026)
Figure 42. North America Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2016-2026)
Figure 43. North America Klebsiella Pneumoniae Infection Drug Sales Market Share by Country (2016-2026)
Figure 44. North America Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country (2016-2026)
Figure 45. United States Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2016-2026)
Figure 49. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2016-2026)
Figure 50. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Country (2016-2026)
Figure 51. Europe Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country (2016-2026)
Figure 52. Germany Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue Market Share by Region (2016-2026)
Figure 61. China Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2016-2026)
Figure 68. South America Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2016-2026)
Figure 69. South America Klebsiella Pneumoniae Infection Drug Sales Market Share by Country (2016-2026)
Figure 70. South America Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界の腸内細菌科感染症薬市場 2021：企業別、地域別、種類・用途別 The Enterobacteriaceae Infection Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…- 世界のCディフィシル感染症治療薬市場 2021：企業別、地域別、種類・用途別 The C Difficile Infection Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界のマールブルグウイルス感染症市場 2021：企業別、地域別、種類・用途別 The Marburgvirus Infection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界のグラム陽性菌感染症治療薬市場 2021：企業別、地域別、種類・用途別 The Gram-positive Bacterial Infection Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界の感染管理歯科用消耗品市場 2021：企業別、地域別、種類・用途別 The Infection Control Dental Consumables market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …